Neil Morris was diagnosed with acute lymphoblastic leukaemia in November 2023 after experiencing what he thought was ...
Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...
A SPORTY nine-year-old described as the “epitome of health” received a shock diagnosis after suffering a "massive" nosebleed. Sammy Balmforth, from Biddulph, Staffordshire, was “born with a ...
Germany: A recent study published in the Leukemia Journal suggests that higher maternal body mass index (BMI) during ...
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in ...
Efforts to cure BCR::ABL1 B cell acute lymphoblastic leukemia (Ph+ ALL) solely through inhibition of ABL1 kinase activity have thus far been insufficient despite the availability of tyrosine kinase ...
It occurs when your child’s bone marrow produces too much of a type of white blood cell called a lymphoblast. The “acute” in ALL means it usually spreads quickly if not treated. AML is the second most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results